Clinical Trial Update: Effect of Silymarin in Metastatic Colorectal Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of silymarin in patients with metastatic colorectal cancer. Status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Tanta University | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN